HealthPolitics

STAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 11/11/2026, 22:06:25 UTC.

Briefings

The Senate health committee scheduled a pivotal vote on November 18, 2026, to confirm Heidi Overton as FDA commissioner. Despite this, committee Chair Bill Cassidy (R-La.) remained undecided on her nomination, as he noted in a post on X that one Republican vote could sink her if all Democrats oppose her. The committee also voted on James O'Neill's nomination for the National Science Foundation director position and three other nominations.

Key points

• Senate health committee scheduled a vote on November 18, 2026, to confirm Heidi Overton as FDA commissioner.
• Committee Chair Bill Cassidy (R-La.) remained undecided on Overton's nomination, noting one Republican vote could sink her if all Democrats oppose her.

Context

The vote on Heidi Overton's nomination for FDA commissioner is scheduled for November 18, 2026, per a committee release. The full Senate will then vote on her nomination before January 2027, when Democrats take power. The committee also voted on James O'Neill's nomination for the National Science Foundation director position and three other nominations.

Limitations

Evidence is limited to a single committee release stating the vote date and Cassidy's uncertainty on Overton. No additional background on the committee's history, prior votes, or specific voting records is supplied. The article does not provide details on the full Senate confirmation process or the status of the other nominations beyond the committee vote.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 12/11/2026, 02:54:55 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiecyda65ezxw54qpiph2whmfdbt36eucdi3qi6epilbg53byt45bu